| Chlorocebus sabaeus |
Vero |
IC50 |
20000.0 |
nM |
10.1016/j.bmcl.2020.127479 |
| Homo sapiens |
26S protease regulatory subunit 6B |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
A498 |
GI50 |
1100.0 |
nM |
10.1021/acs.jmedchem.0c00193 |
| Homo sapiens |
A549 |
IC50 |
330.0 |
nM |
10.1039/C5MD00364D |
| Homo sapiens |
Acetylcholinesterase |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Actin-related protein 2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Actin-related protein 3 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Activin receptor type-1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Activin receptor type-1B |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Activin receptor type-2B |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Acyl-CoA dehydrogenase family member 10 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Acyl-CoA dehydrogenase family member 11 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Adaptor-associated kinase |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Adenine phosphoribosyltransferase |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine kinase |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Adenylate kinase 2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
ADP/ATP translocase 2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
ADP/ATP translocase 3 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
AMP-activated protein kinase, alpha-1 subunit |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
AMP-activated protein kinase, gamma-1 subunit |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
AMP-activated protein kinase, gamma-2 subunit |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
ATP-dependent RNA helicase DDX1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
ATP-dependent RNA helicase DDX3X |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
ATP-dependent RNA helicase DDX42 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
ATP-dependent RNA helicase DHX30 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Bel-7402 |
Activity |
0.32 |
g |
10.1021/acs.jmedchem.1c01520 |
| Homo sapiens |
Bel-7402 |
Activity |
5.52 |
% |
10.1021/acs.jmedchem.1c01520 |
| Homo sapiens |
Bel-7402 |
Activity |
14.41 |
None |
10.1021/acs.jmedchem.1c01520 |
| Homo sapiens |
Bel-7402 |
Activity |
nan |
None |
10.1021/acs.jmedchem.1c01520 |
| Homo sapiens |
Bel-7402 |
IC50 |
66230.0 |
nM |
10.1021/acs.jmedchem.1c01520 |
| Homo sapiens |
Bel-7402 |
Inhibition |
9.0 |
% |
10.1021/acs.jmedchem.1c01520 |
| Homo sapiens |
Bel-7402 |
Inhibition |
44.56 |
% |
10.1021/acs.jmedchem.1c01520 |
| Homo sapiens |
Bel-7402 |
T/C |
56.1 |
% |
10.1021/acs.jmedchem.1c01520 |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
AC50 |
17999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
BMP-2-inducible protein kinase |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Bone morphogenetic protein receptor type-1A |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Bone morphogenetic protein receptor type-1B |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Bone morphogenetic protein receptor type-2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Brain glycogen phosphorylase |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Breakpoint cluster region protein |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Bromodomain-containing protein 4 |
Delta TM |
-1.67 |
C |
None |
| Homo sapiens |
Bromodomain-containing protein 4 |
Delta TM |
0.03447 |
C |
None |
| Homo sapiens |
CAKI-1 |
GI50 |
20500.0 |
nM |
10.1021/acs.jmedchem.0c00193 |
| Homo sapiens |
CaM kinase II delta |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
CaM kinase II gamma |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
CaM kinase IV |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
CaM-kinase kinase beta |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
cAMP-dependent protein kinase alpha-catalytic subunit |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
cAMP-dependent protein kinase beta-1 catalytic subunit |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
cAMP-dependent protein kinase, gamma catalytic subunit |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
cAMP-dependent protein kinase type II-alpha regulatory subunit |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Casein kinase I alpha |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Casein kinase I delta |
Delta TM |
-0.1565 |
C |
None |
| Homo sapiens |
Casein kinase I delta |
Delta TM |
0.0 |
C |
None |
| Homo sapiens |
Casein kinase I delta |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Casein kinase I epsilon |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Casein kinase I gamma 1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Casein kinase I gamma 2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Casein kinase II alpha (prime) |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Casein kinase I isoform gamma-3 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
CCRF-CEM |
GI50 |
22300.0 |
nM |
10.1021/acs.jmedchem.0c00193 |
| Homo sapiens |
cGMP-dependent protein kinase 1 beta |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Chaperone activity of bc1 complex-like, mitochondrial |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Chromodomain-helicase-DNA-binding protein 4 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Citron Rho-interacting kinase |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
c-Jun N-terminal kinase 1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
c-Jun N-terminal kinase 2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
c-Jun N-terminal kinase 3 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Cyclin-dependent kinase 1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Cyclin-dependent kinase 12 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Cyclin-dependent kinase 13 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Cyclin-dependent kinase 2 |
Delta TM |
-0.6419 |
C |
None |
| Homo sapiens |
Cyclin-dependent kinase 2 |
Delta TM |
0.39 |
C |
None |
| Homo sapiens |
Cyclin-dependent kinase 2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Cyclin-dependent kinase 3 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Cyclin-dependent kinase 4 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Cyclin-dependent kinase 5 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Cyclin-dependent kinase 6 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Cyclin-dependent kinase 7 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Cyclin-dependent kinase 9 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Cyclin-dependent kinase-like 5 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
4996.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cysteine--tRNA ligase, cytoplasmic |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Cytochrome c1, heme protein, mitochondrial |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
dCTP pyrophosphatase 1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Delta(24)-sterol reductase |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Deoxycytidine kinase |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Discoidin domain-containing receptor 2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
DNA-dependent protein kinase |
IC50 |
6700.0 |
nM |
10.1021/acs.jmedchem.6b00963 |
| Homo sapiens |
DNA-dependent protein kinase |
IC50 |
6700.0 |
nM |
10.1021/ml500354e |
| Homo sapiens |
DnaJ homolog subfamily A member 1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
DNA replication licensing factor MCM4 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
DNA topoisomerase II alpha |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
DNA topoisomerase II beta |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
DOHH-2 |
Activity |
38.1 |
% |
10.1016/j.ejmech.2022.114232 |
| Homo sapiens |
DOHH-2 |
Activity |
57.9 |
% |
10.1016/j.ejmech.2022.114232 |
| Homo sapiens |
DOHH-2 |
IC50 |
860.0 |
nM |
10.1016/j.ejmech.2022.114232 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
9590.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dual specificity mitogen-activated protein kinase kinase 1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Dual specificity mitogen-activated protein kinase kinase 2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Dual specificity mitogen-activated protein kinase kinase 3 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Dual specificity mitogen-activated protein kinase kinase 4 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Dual specificity mitogen-activated protein kinase kinase 5 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Dual specificity mitogen-activated protein kinase kinase 6 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Dual specificity protein kinase CLK2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Dual specificity protein kinase CLK4 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Dual specificity testis-specific protein kinase 1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Dual specificity testis-specific protein kinase 2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Dual-specificity tyrosine-phosphorylation regulated kinase 1A |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Dual specificity tyrosine-phosphorylation-regulated kinase 1B |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Dual specificty protein kinase CLK1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Dynamin-like 120 kDa protein, mitochondrial |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Electron transfer flavoprotein subunit beta |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Elongation factor Tu, mitochondrial |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
EOL1 |
IC50 |
50000.0 |
nM |
10.1016/j.bmcl.2023.129152 |
| Homo sapiens |
Ephrin type-A receptor 1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Ephrin type-A receptor 2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Ephrin type-A receptor 4 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Ephrin type-A receptor 5 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Ephrin type-A receptor 7 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Ephrin type-B receptor 2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Ephrin type-B receptor 3 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Ephrin type-B receptor 4 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Ephrin type-B receptor 6 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Epithelial discoidin domain-containing receptor 1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Eukaryotic translation initiation factor 2-alpha kinase 1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Eukaryotic translation initiation factor 5B |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Exosome RNA helicase MTR4 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Ferrochelatase, mitochondrial |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Fibroblast |
Control DMSO Apoptotic Cells (%) |
52.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Apoptotic Cells (%) |
55.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Apoptotic Cells (%) |
65.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Apoptotic Cells (%) |
69.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Apoptotic Cells (%) |
80.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Fragmented Nuclei % |
25.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Fragmented Nuclei % |
27.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Fragmented Nuclei % |
55.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Fragmented Nuclei % |
58.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Fragmented Nuclei % |
59.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Growth Rate |
0.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Growth Rate |
1.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Growth Rate |
7.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Growth Rate |
231110.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Healthy Nuclei (%) |
29.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Healthy Nuclei (%) |
31.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Healthy Nuclei (%) |
34.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Healthy Nuclei (%) |
53.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Healthy Nuclei (%) |
59.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Healthy Nuclei (%) |
61.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Membrane Permeable-Phenotype Cells (%) |
2.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Membrane Permeable-Phenotype Cells (%) |
4.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Membrane Permeable-Phenotype Cells (%) |
5.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Membrane Permeable-Phenotype Cells (%) |
9.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Membrane Permeable-Phenotype Cells (%) |
10.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Mitochondria Different-Phenotype Cells (%) |
1.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Mitochondria Different-Phenotype Cells (%) |
3.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Mitochondria Different-Phenotype Cells (%) |
10.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Mitochondria Different-Phenotype Cells (%) |
12.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Mitochondria Different-Phenotype Cells (%) |
14.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Mitochondria Different-Phenotype Cells (%) |
29.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Mitotic Cells (%) |
19.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Mitotic Cells (%) |
30.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Mitotic Cells (%) |
34.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Mitotic Cells (%) |
44.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Mitotic Cells (%) |
47.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Pyknosed Nuclei (%) |
9.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Pyknosed Nuclei (%) |
10.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Pyknosed Nuclei (%) |
11.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Pyknosed Nuclei (%) |
13.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Pyknosed Nuclei (%) |
14.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Pyknosed Nuclei (%) |
18.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Total Cells |
80.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Total Cells |
84.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Total Cells |
99.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Total Cells |
211.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Total Cells |
230.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Total Cells |
242.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Tubulin Phenotype Different Cells (%) |
2.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Tubulin Phenotype Different Cells (%) |
3.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Tubulin Phenotype Different Cells (%) |
11.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Control DMSO Tubulin Phenotype Different Cells (%) |
12.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Growth Rate |
-0.73 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
Fibroblast |
Growth Rate |
-0.51 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Fibroblast |
Growth Rate |
-0.13 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
Fibroblast |
Growth Rate |
-0.05 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
Fibroblast |
Growth Rate |
-0.04 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.15 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.25 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.36 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.48 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.49 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.59 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.75 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.92 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.95 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Fibroblast |
Growth Rate |
1.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Apoptotic (%) |
0.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Apoptotic (%) |
40.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Apoptotic (%) |
50.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Apoptotic (%) |
58.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Apoptotic (%) |
59.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Apoptotic (%) |
66.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Apoptotic (%) |
73.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Apoptotic (%) |
85.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Apoptotic (%) |
91.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Apoptotic (%) |
95.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Fragmented Nuclei (%) |
22.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Fragmented Nuclei (%) |
26.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Fragmented Nuclei (%) |
27.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Fragmented Nuclei (%) |
30.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Fragmented Nuclei (%) |
36.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Fragmented Nuclei (%) |
47.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Fragmented Nuclei (%) |
56.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Fragmented Nuclei (%) |
58.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Fragmented Nuclei (%) |
67.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Fragmented Nuclei (%) |
70.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Healthy Nuclei (%) |
22.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Healthy Nuclei (%) |
25.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Healthy Nuclei (%) |
30.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Healthy Nuclei (%) |
33.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Healthy Nuclei (%) |
34.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Healthy Nuclei (%) |
43.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Healthy Nuclei (%) |
47.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Healthy Nuclei (%) |
51.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Healthy Nuclei (%) |
54.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Healthy Nuclei (%) |
56.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Healthy Nuclei (%) |
59.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Hoechst High Intensity Objects (%) |
9.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Hoechst High Intensity Objects (%) |
10.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Hoechst High Intensity Objects (%) |
11.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Hoechst High Intensity Objects (%) |
12.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Hoechst High Intensity Objects (%) |
13.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Hoechst High Intensity Objects (%) |
22.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Hoechst High Intensity Objects (%) |
30.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Hoechst High Intensity Objects (%) |
34.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Hoechst High Intensity Objects (%) |
35.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Hoechst High Intensity Objects (%) |
43.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Membrane Permeable-Phenotype (%) |
0.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Membrane Permeable-Phenotype (%) |
2.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Membrane Permeable-Phenotype (%) |
6.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Membrane Permeable-Phenotype (%) |
7.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Membrane Permeable-Phenotype (%) |
12.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Membrane Permeable-Phenotype (%) |
14.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Membrane Permeable-Phenotype (%) |
15.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Membrane Permeable-Phenotype (%) |
18.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Membrane Permeable-Phenotype (%) |
26.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Mitochondria Different-Phenotype (%) |
0.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Mitochondria Different-Phenotype (%) |
1.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Mitochondria Different-Phenotype (%) |
5.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Mitochondria Different-Phenotype (%) |
6.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Mitochondria Different-Phenotype (%) |
7.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Mitochondria Different-Phenotype (%) |
15.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Mitochondria Different-Phenotype (%) |
25.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Mitochondria Different-Phenotype (%) |
26.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Mitochondria Different-Phenotype (%) |
31.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Mitochondria Different-Phenotype (%) |
35.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Mitochondria Different-Phenotype (%) |
36.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Mitotic Cells (%) |
4.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Mitotic Cells (%) |
8.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Mitotic Cells (%) |
14.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Mitotic Cells (%) |
26.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Mitotic Cells (%) |
33.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Mitotic Cells (%) |
40.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Mitotic Cells (%) |
41.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Mitotic Cells (%) |
50.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Mitotic Cells (%) |
60.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Mitotic Cells (%) |
100.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Normal (%) |
56.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Normal (%) |
65.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Normal (%) |
69.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Normal (%) |
77.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Normal (%) |
86.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Normal (%) |
87.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Normal (%) |
88.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Normal (%) |
89.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Normal (%) |
90.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Pyknosed Nuclei (%) |
5.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Pyknosed Nuclei (%) |
8.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Pyknosed Nuclei (%) |
9.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Pyknosed Nuclei (%) |
12.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Pyknosed Nuclei (%) |
13.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Pyknosed Nuclei (%) |
16.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Pyknosed Nuclei (%) |
17.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Tubulin-Different-Phenotype (%) |
1.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Tubulin-Different-Phenotype (%) |
2.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Tubulin-Different-Phenotype (%) |
4.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Tubulin-Different-Phenotype (%) |
15.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Tubulin-Different-Phenotype (%) |
20.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Tubulin-Different-Phenotype (%) |
21.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Tubulin-Different-Phenotype (%) |
25.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Tubulin-Different-Phenotype (%) |
28.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Tubulin-Different-Phenotype (%) |
33.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Population Tubulin-Different-Phenotype (%) |
53.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Total Cell Count |
60.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Total Cell Count |
63.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Total Cell Count |
67.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Total Cell Count |
73.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Total Cell Count |
77.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Total Cell Count |
110.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Total Cell Count |
156.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Total Cell Count |
184.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Total Cell Count |
199.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Total Cell Count |
211.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Total Cell Count |
221.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Total Cell Count |
222.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast growth factor receptor 1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Fibroblast growth factor receptor 3 |
Delta TM |
0.03 |
C |
None |
| Homo sapiens |
Fibroblast growth factor receptor 3 |
Delta TM |
0.05233 |
C |
None |
| Homo sapiens |
Focal adhesion kinase 1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
General transcription and DNA repair factor IIH helicase subunit XPD |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Glycine--tRNA ligase |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Glycogen synthase kinase-3 alpha |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Glycogen synthase kinase-3 beta |
Delta TM |
-0.32 |
C |
None |
| Homo sapiens |
Glycogen synthase kinase-3 beta |
Delta TM |
-0.008089 |
C |
None |
| Homo sapiens |
Glycogen synthase kinase-3 beta |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
G-protein coupled receptor kinase 2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
G protein-coupled receptor kinase 6 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
GTP-binding nuclear protein Ran |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Guanine nucleotide-binding protein G(i) subunit alpha-2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
HCC 2998 |
GI50 |
38500.0 |
nM |
10.1021/acs.jmedchem.0c00193 |
| Homo sapiens |
HCT-116 |
IC50 |
2960.0 |
nM |
10.1016/j.bmc.2022.117028 |
| Homo sapiens |
HCT-116 |
IC50 |
10000.0 |
nM |
10.1016/j.bmc.2019.07.051 |
| Homo sapiens |
HEK293 |
IC50 |
20000.0 |
nM |
10.1016/j.bmcl.2020.127479 |
| Homo sapiens |
HEK-293T |
Control DMSO Apoptotic Cells (%) |
8.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Apoptotic Cells (%) |
13.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Apoptotic Cells (%) |
14.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Apoptotic Cells (%) |
15.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Apoptotic Cells (%) |
16.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Apoptotic Cells (%) |
18.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Fragmented Nuclei % |
5.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Fragmented Nuclei % |
9.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Fragmented Nuclei % |
13.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Fragmented Nuclei % |
14.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Fragmented Nuclei % |
18.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Fragmented Nuclei % |
23.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Growth Rate |
0.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Growth Rate |
1.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Healthy Nuclei (%) |
49.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Healthy Nuclei (%) |
69.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Healthy Nuclei (%) |
73.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Healthy Nuclei (%) |
77.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Healthy Nuclei (%) |
79.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Healthy Nuclei (%) |
86.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Membrane Permeable-Phenotype Cells (%) |
0.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Membrane Permeable-Phenotype Cells (%) |
1.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Membrane Permeable-Phenotype Cells (%) |
3.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Membrane Permeable-Phenotype Cells (%) |
4.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Membrane Permeable-Phenotype Cells (%) |
7.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Mitochondria Different-Phenotype Cells (%) |
3.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Mitochondria Different-Phenotype Cells (%) |
4.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Mitochondria Different-Phenotype Cells (%) |
7.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Mitochondria Different-Phenotype Cells (%) |
12.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Mitochondria Different-Phenotype Cells (%) |
22.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Mitochondria Different-Phenotype Cells (%) |
32.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Mitotic Cells (%) |
81.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Mitotic Cells (%) |
83.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Mitotic Cells (%) |
84.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Mitotic Cells (%) |
85.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Mitotic Cells (%) |
86.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Mitotic Cells (%) |
91.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Pyknosed Nuclei (%) |
4.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Pyknosed Nuclei (%) |
7.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Pyknosed Nuclei (%) |
15.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Pyknosed Nuclei (%) |
16.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Pyknosed Nuclei (%) |
27.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Total Cells |
691.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Total Cells |
838.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Total Cells |
865.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Total Cells |
1080.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Total Cells |
1765.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Total Cells |
3025.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Tubulin Phenotype Different Cells (%) |
0.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Tubulin Phenotype Different Cells (%) |
1.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Tubulin Phenotype Different Cells (%) |
2.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Tubulin Phenotype Different Cells (%) |
3.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Tubulin Phenotype Different Cells (%) |
4.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Control DMSO Tubulin Phenotype Different Cells (%) |
45.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Growth Rate |
-0.34 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.12 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.2 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.29 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.31 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.36 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.38 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.52 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.56 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.57 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.62 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.64 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.68 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.7 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.76 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
HEK-293T |
Population Apoptotic (%) |
3.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Apoptotic (%) |
8.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Apoptotic (%) |
10.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Apoptotic (%) |
12.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Apoptotic (%) |
13.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Apoptotic (%) |
14.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Apoptotic (%) |
15.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Apoptotic (%) |
17.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Apoptotic (%) |
18.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Apoptotic (%) |
22.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Fragmented Nuclei (%) |
4.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Fragmented Nuclei (%) |
5.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Fragmented Nuclei (%) |
8.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Fragmented Nuclei (%) |
11.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Fragmented Nuclei (%) |
14.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Fragmented Nuclei (%) |
15.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Fragmented Nuclei (%) |
17.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Fragmented Nuclei (%) |
18.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Fragmented Nuclei (%) |
20.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Fragmented Nuclei (%) |
24.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Fragmented Nuclei (%) |
29.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Healthy Nuclei (%) |
43.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Healthy Nuclei (%) |
44.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Healthy Nuclei (%) |
46.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Healthy Nuclei (%) |
60.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Healthy Nuclei (%) |
67.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Healthy Nuclei (%) |
68.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Healthy Nuclei (%) |
77.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Healthy Nuclei (%) |
78.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Healthy Nuclei (%) |
85.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Healthy Nuclei (%) |
86.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Hoechst High Intensity Objects (%) |
2.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Hoechst High Intensity Objects (%) |
3.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Hoechst High Intensity Objects (%) |
5.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Hoechst High Intensity Objects (%) |
9.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Hoechst High Intensity Objects (%) |
10.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Hoechst High Intensity Objects (%) |
14.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Hoechst High Intensity Objects (%) |
18.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Hoechst High Intensity Objects (%) |
20.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Membrane Permeable-Phenotype (%) |
0.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Membrane Permeable-Phenotype (%) |
1.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Membrane Permeable-Phenotype (%) |
3.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Membrane Permeable-Phenotype (%) |
4.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Membrane Permeable-Phenotype (%) |
5.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Membrane Permeable-Phenotype (%) |
8.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Membrane Permeable-Phenotype (%) |
11.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Membrane Permeable-Phenotype (%) |
12.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Membrane Permeable-Phenotype (%) |
16.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Membrane Permeable-Phenotype (%) |
28.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Mitochondria Different-Phenotype (%) |
1.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Mitochondria Different-Phenotype (%) |
3.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Mitochondria Different-Phenotype (%) |
4.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Mitochondria Different-Phenotype (%) |
8.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Mitochondria Different-Phenotype (%) |
10.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Mitochondria Different-Phenotype (%) |
12.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Mitochondria Different-Phenotype (%) |
13.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Mitochondria Different-Phenotype (%) |
15.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Mitochondria Different-Phenotype (%) |
18.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Mitochondria Different-Phenotype (%) |
22.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Mitochondria Different-Phenotype (%) |
28.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Mitotic Cells (%) |
77.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Mitotic Cells (%) |
81.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Mitotic Cells (%) |
82.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Mitotic Cells (%) |
84.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Mitotic Cells (%) |
85.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Mitotic Cells (%) |
87.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Mitotic Cells (%) |
89.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Mitotic Cells (%) |
91.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Mitotic Cells (%) |
96.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Normal (%) |
80.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Normal (%) |
81.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Normal (%) |
85.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Normal (%) |
89.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Normal (%) |
91.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Normal (%) |
94.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Normal (%) |
96.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Normal (%) |
97.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Pyknosed Nuclei (%) |
2.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Pyknosed Nuclei (%) |
4.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Pyknosed Nuclei (%) |
5.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Pyknosed Nuclei (%) |
9.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Pyknosed Nuclei (%) |
10.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Pyknosed Nuclei (%) |
17.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Pyknosed Nuclei (%) |
18.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Pyknosed Nuclei (%) |
23.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Pyknosed Nuclei (%) |
31.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Pyknosed Nuclei (%) |
34.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Pyknosed Nuclei (%) |
35.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Tubulin-Different-Phenotype (%) |
0.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Tubulin-Different-Phenotype (%) |
1.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Tubulin-Different-Phenotype (%) |
2.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Tubulin-Different-Phenotype (%) |
7.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Tubulin-Different-Phenotype (%) |
29.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Tubulin-Different-Phenotype (%) |
48.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Tubulin-Different-Phenotype (%) |
64.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Population Tubulin-Different-Phenotype (%) |
68.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Total Cell Count |
500.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Total Cell Count |
587.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Total Cell Count |
588.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Total Cell Count |
613.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Total Cell Count |
888.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Total Cell Count |
911.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Total Cell Count |
995.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Total Cell Count |
1058.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Total Cell Count |
1315.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Total Cell Count |
1603.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Total Cell Count |
2065.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Total Cell Count |
2772.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HeLa |
IC50 |
150.0 |
nM |
10.1039/C5MD00364D |
| Homo sapiens |
Heme oxygenase 2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Hep 3B2 |
IC50 |
77550.0 |
nM |
10.1021/acs.jmedchem.1c01520 |
| Homo sapiens |
Hep 3B2 |
Inhibition |
21.0 |
% |
10.1021/acs.jmedchem.1c01520 |
| Homo sapiens |
Hepatocyte growth factor receptor |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
HepG2 |
IC50 |
920.0 |
nM |
10.1039/C5MD00364D |
| Homo sapiens |
HepG2 |
IC50 |
89500.0 |
nM |
10.1021/acs.jmedchem.1c01520 |
| Homo sapiens |
HepG2 |
Inhibition |
20.0 |
% |
10.1021/acs.jmedchem.1c01520 |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 1 |
IC50 |
nan |
None |
10.1016/j.bmc.2022.117028 |
| Homo sapiens |
Histone deacetylase 6 |
IC50 |
nan |
None |
10.1016/j.bmc.2022.117028 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-5.22 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-3.14 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
HL-60 |
IC50 |
480.0 |
nM |
10.1016/j.bmcl.2023.129152 |
| Homo sapiens |
Homo sapiens |
Activity |
56.0 |
% |
10.1021/jm300847w |
| Homo sapiens |
Homo sapiens |
MTD |
200.0 |
mg |
10.1021/jm300847w |
| Homo sapiens |
Homo sapiens |
MTD |
400.0 |
mg |
10.1021/jm300847w |
| Homo sapiens |
HOP-62 |
GI50 |
100000.0 |
nM |
10.1021/acs.jmedchem.0c00193 |
| Homo sapiens |
HOP-92 |
GI50 |
14100.0 |
nM |
10.1021/acs.jmedchem.0c00193 |
| Homo sapiens |
Hs-578T |
GI50 |
6000.0 |
nM |
10.1021/acs.jmedchem.0c00193 |
| Homo sapiens |
HT |
IC50 |
10000.0 |
nM |
10.1016/j.ejmech.2016.11.014 |
| Homo sapiens |
HUVEC |
IC50 |
38220.0 |
nM |
10.1016/j.bmc.2022.117028 |
| Homo sapiens |
IGROV-1 |
GI50 |
4800.0 |
nM |
10.1021/acs.jmedchem.0c00193 |
| Homo sapiens |
Inhibitor of nuclear factor kappa B kinase epsilon subunit |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Inosine-5'-monophosphate dehydrogenase 2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Insulin-like growth factor I receptor |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Insulin receptor |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Interleukin-1 receptor-associated kinase 1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Interleukin-1 receptor-associated kinase 3 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Interleukin-1 receptor-associated kinase 4 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
JeKo-1 |
IC50 |
120.0 |
nM |
10.1016/j.bmcl.2020.127479 |
| Homo sapiens |
KARPAS-422 |
GI50 |
680.0 |
nM |
10.1021/acsmedchemlett.7b00222 |
| Homo sapiens |
KARPAS-422 |
IC50 |
8100.0 |
nM |
10.1016/j.ejmech.2016.11.014 |
| Homo sapiens |
KG-1 |
IC50 |
15200.0 |
nM |
10.1016/j.bmcl.2023.129152 |
| Homo sapiens |
KM12 |
GI50 |
1200.0 |
nM |
10.1021/acs.jmedchem.0c00193 |
| Homo sapiens |
KM12 |
IC50 |
960.0 |
nM |
10.1016/j.bmc.2022.117028 |
| Homo sapiens |
L02 |
IC50 |
20000.0 |
nM |
10.1016/j.bmcl.2020.127479 |
| Homo sapiens |
LIM domain kinase 1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
LIM domain kinase 2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Liver glycogen phosphorylase |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Long-chain-fatty-acid--CoA ligase 5 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
LOX IMVI |
GI50 |
33500.0 |
nM |
10.1021/acs.jmedchem.0c00193 |
| Homo sapiens |
M14 |
GI50 |
37800.0 |
nM |
10.1021/acs.jmedchem.0c00193 |
| Homo sapiens |
Macrophage-stimulating protein receptor |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
MAP kinase-activated protein kinase 2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
MAP kinase-activated protein kinase 3 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
MAP kinase-activated protein kinase 5 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
MAP kinase ERK1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
MAP kinase ERK2 |
Delta TM |
-0.09 |
C |
None |
| Homo sapiens |
MAP kinase ERK2 |
Delta TM |
-0.04486 |
C |
None |
| Homo sapiens |
MAP kinase ERK2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
MAP kinase p38 alpha |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
MAP kinase p38 beta |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
MAP/microtubule affinity-regulating kinase 2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
MAP/microtubule affinity-regulating kinase 4 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Maternal embryonic leucine zipper kinase |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
MCF7 |
GI50 |
nan |
None |
10.1021/acsmedchemlett.7b00222 |
| Homo sapiens |
MCF7 |
IC50 |
780.0 |
nM |
10.1039/C5MD00364D |
| Homo sapiens |
MCF7 |
IC50 |
10000.0 |
nM |
10.1016/j.bmc.2019.07.051 |
| Homo sapiens |
MDA-MB-231 |
GI50 |
42300.0 |
nM |
10.1021/acs.jmedchem.0c00193 |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Membrane-associated progesterone receptor component 1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Midasin |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Misshapen-like kinase 1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Mitogen-activated protein kinase 15 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Mitogen-activated protein kinase 7 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Mitogen-activated protein kinase kinase kinase 1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Mitogen-activated protein kinase kinase kinase 11 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Mitogen-activated protein kinase kinase kinase 2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Mitogen-activated protein kinase kinase kinase 3 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Mitogen-activated protein kinase kinase kinase 4 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Mitogen-activated protein kinase kinase kinase 5 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Mitogen-activated protein kinase kinase kinase 6 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Mitogen-activated protein kinase kinase kinase kinase 1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Mitogen-activated protein kinase kinase kinase kinase 2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Mitogen-activated protein kinase kinase kinase kinase 3 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Mitogen-activated protein kinase kinase kinase kinase 4 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Mitogen-activated protein kinase kinase kinase kinase 5 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Mitotic checkpoint serine/threonine-protein kinase BUB1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Mixed lineage kinase 7 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
MOLM-13 |
GI50 |
1700.0 |
nM |
10.1016/j.ejmech.2018.07.036 |
| Homo sapiens |
MOLM-14 |
Activity |
nan |
None |
10.1016/j.ejmech.2018.07.036 |
| Homo sapiens |
MOLM-14 |
GI50 |
6400.0 |
nM |
10.1016/j.ejmech.2018.07.036 |
| Homo sapiens |
MOLM-14 |
TGI |
nan |
None |
10.1016/j.ejmech.2018.07.036 |
| Homo sapiens |
MOLT-4 |
Activity |
2.34 |
% |
10.1016/j.bmc.2021.116312 |
| Homo sapiens |
MOLT-4 |
Activity |
19.2 |
% |
10.1016/j.bmc.2021.116312 |
| Homo sapiens |
MOLT-4 |
Activity |
22.0 |
% |
10.1016/j.bmc.2021.116312 |
| Homo sapiens |
MOLT-4 |
Activity |
56.5 |
% |
10.1016/j.bmc.2021.116312 |
| Homo sapiens |
MOLT-4 |
Activity |
74.57 |
% |
10.1016/j.bmc.2021.116312 |
| Homo sapiens |
MOLT-4 |
IC50 |
10000.0 |
nM |
10.1016/j.ejmech.2016.11.014 |
| Homo sapiens |
MOLT-4 |
Inhibition |
nan |
% |
10.1016/j.bmc.2021.116312 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
MRC5 |
IC50 |
100000.0 |
nM |
10.1016/j.bmc.2021.116312 |
| Homo sapiens |
MRC5 |
Inhibition |
18.41 |
% |
10.1016/j.bmc.2021.116312 |
| Homo sapiens |
Multifunctional protein ADE2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
14610.3 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
MV4-11 |
GI50 |
10000.0 |
nM |
10.1016/j.ejmech.2018.07.036 |
| Homo sapiens |
MV4-11 |
IC50 |
4300.0 |
nM |
10.1016/j.bmcl.2023.129152 |
| Homo sapiens |
MV4-11 |
Inhibition |
nan |
% |
10.1021/acs.jmedchem.0c00193 |
| Homo sapiens |
Myosin light chain kinase |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Myosin light chain kinase, smooth muscle |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
NALM-6 |
GI50 |
10000.0 |
nM |
10.1016/j.ejmech.2018.07.036 |
| Homo sapiens |
NAMALVA |
IC50 |
10000.0 |
nM |
10.1016/j.ejmech.2016.11.014 |
| Homo sapiens |
NCI-H460 |
GI50 |
nan |
None |
10.1021/acsmedchemlett.7b00222 |
| Homo sapiens |
Nerve growth factor receptor Trk-A |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neutrophil |
IC50 |
70.0 |
nM |
10.1021/acs.jnatprod.5b01142 |
| Homo sapiens |
Neutrophil |
IC50 |
300.0 |
nM |
10.1021/acs.jnatprod.5b01142 |
| Homo sapiens |
Neutrophil |
Inhibition |
100.0 |
% |
10.1021/acs.jnatprod.5b01142 |
| Homo sapiens |
Neutrophil |
Inhibition |
103.0 |
% |
10.1021/acs.jnatprod.5b01142 |
| Homo sapiens |
Non-receptor tyrosine-protein kinase TNK1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
NUAK family SNF1-like kinase 2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Nucleolar GTP-binding protein 1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
OCI-Ly10 |
Activity |
0.48 |
g |
10.1021/acs.jmedchem.0c01264 |
| Homo sapiens |
OCI-Ly10 |
Activity |
828.42 |
mm3 |
10.1021/acs.jmedchem.0c01264 |
| Homo sapiens |
OCI-Ly10 |
IC50 |
31.9 |
nM |
10.1021/acs.jmedchem.0c01264 |
| Homo sapiens |
OCI-Ly10 |
IC50 |
10000.0 |
nM |
10.1016/j.bmcl.2020.127479 |
| Homo sapiens |
OCI-Ly10 |
TGI |
47.33 |
% |
10.1021/acs.jmedchem.0c01264 |
| Homo sapiens |
OCI-Ly3 |
IC50 |
5200.0 |
nM |
10.1016/j.bmcl.2020.127479 |
| Homo sapiens |
OVCAR-3 |
GI50 |
17700.0 |
nM |
10.1021/acs.jmedchem.0c00193 |
| Homo sapiens |
PAS domain-containing serine/threonine-protein kinase |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Peregrin |
Delta TM |
-1.86 |
C |
None |
| Homo sapiens |
Peregrin |
Delta TM |
0.4331 |
C |
None |
| Homo sapiens |
Peroxisomal acyl-coenzyme A oxidase 1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Peroxisomal acyl-coenzyme A oxidase 3 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
PF-382 |
GI50 |
10000.0 |
nM |
10.1016/j.ejmech.2018.07.036 |
| Homo sapiens |
Pfeiffer |
GI50 |
740.0 |
nM |
10.1021/acsmedchemlett.7b00222 |
| Homo sapiens |
Pfeiffer |
IC50 |
6800.0 |
nM |
10.1016/j.ejmech.2016.11.014 |
| Homo sapiens |
Phenylalanine--tRNA ligase beta subunit |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Phosphatidylethanolamine-binding protein 1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Phosphatidylinositol 3-kinase catalytic subunit type 3 |
IC50 |
980.0 |
nM |
10.1021/acs.jmedchem.8b01298 |
| Homo sapiens |
Phosphatidylinositol 3-kinase catalytic subunit type 3 |
IC50 |
4417.0 |
nM |
10.1016/j.ejmech.2018.07.036 |
| Homo sapiens |
Phosphatidylinositol 3-kinase catalytic subunit type 3 |
IC50 |
978000.0 |
nM |
10.1021/acs.jmedchem.6b00963 |
| Homo sapiens |
Phosphatidylinositol 3-kinase regulatory subunit beta/Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform |
IC50 |
579.0 |
nM |
10.1039/C5MD00364D |
| Homo sapiens |
Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing beta polypeptide |
IC50 |
1000.0 |
nM |
10.1021/acs.jmedchem.6b00963 |
| Homo sapiens |
Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing beta polypeptide |
IC50 |
1000.0 |
nM |
10.1021/ml500354e |
| Homo sapiens |
Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing beta polypeptide |
IC50 |
10000.0 |
nM |
10.1016/j.ejmech.2018.07.036 |
| Homo sapiens |
Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing subunit alpha |
IC50 |
10000.0 |
nM |
10.1016/j.ejmech.2018.07.036 |
| Homo sapiens |
Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing subunit alpha |
IC50 |
nan |
None |
10.1021/ml500354e |
| Homo sapiens |
Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing subunit gamma |
IC50 |
nan |
None |
10.1021/ml500354e |
| Homo sapiens |
Phosphatidylinositol-5-phosphate 4-kinase type-2 alpha |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Phosphatidylinositol-5-phosphate 4-kinase type-2 gamma |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
15153.7 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
17999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphofructokinase platelet type |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Phosphorylase kinase gamma subunit 2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
PI3-kinase p110-alpha/p85-alpha |
IC50 |
409.0 |
nM |
10.1016/j.bmc.2021.116312 |
| Homo sapiens |
PI3-kinase p110-alpha/p85-alpha |
IC50 |
800.0 |
nM |
10.1016/j.ejmech.2018.11.072 |
| Homo sapiens |
PI3-kinase p110-alpha/p85-alpha |
IC50 |
825.0 |
nM |
10.1039/C5MD00364D |
| Homo sapiens |
PI3-kinase p110-alpha/p85-alpha |
IC50 |
2000.0 |
nM |
10.1016/j.ejmech.2018.09.033 |
| Homo sapiens |
PI3-kinase p110-alpha/p85-alpha |
IC50 |
2164.0 |
nM |
10.1016/j.ejmech.2019.03.005 |
| Homo sapiens |
PI3-kinase p110-alpha/p85-alpha |
IC50 |
7500.0 |
nM |
10.1021/acs.jmedchem.6b01821 |
| Homo sapiens |
PI3-kinase p110-alpha/p85-alpha |
IC50 |
8600.0 |
nM |
10.1021/acs.jmedchem.9b00640 |
| Homo sapiens |
PI3-kinase p110-alpha subunit |
IC50 |
177.2 |
nM |
10.1016/j.bmc.2019.07.051 |
| Homo sapiens |
PI3-kinase p110-alpha subunit |
IC50 |
306.4 |
nM |
10.1016/j.bmc.2018.03.002 |
| Homo sapiens |
PI3-kinase p110-alpha subunit |
IC50 |
332.0 |
nM |
10.1016/j.bmcl.2023.129152 |
| Homo sapiens |
PI3-kinase p110-alpha subunit |
IC50 |
391.3 |
nM |
10.1016/j.ejmech.2018.07.036 |
| Homo sapiens |
PI3-kinase p110-alpha subunit |
IC50 |
467.0 |
nM |
10.1016/j.bmc.2022.117028 |
| Homo sapiens |
PI3-kinase p110-alpha subunit |
IC50 |
500.0 |
nM |
10.1016/j.bmcl.2020.127479 |
| Homo sapiens |
PI3-kinase p110-alpha subunit |
IC50 |
583.0 |
nM |
10.1016/j.bmc.2019.05.043 |
| Homo sapiens |
PI3-kinase p110-alpha subunit |
IC50 |
737.0 |
nM |
10.1016/j.ejmech.2018.03.068 |
| Homo sapiens |
PI3-kinase p110-alpha subunit |
IC50 |
800.0 |
nM |
10.1016/j.bmcl.2017.01.077 |
| Homo sapiens |
PI3-kinase p110-alpha subunit |
IC50 |
800.0 |
nM |
10.1021/acs.jmedchem.7b00618 |
| Homo sapiens |
PI3-kinase p110-alpha subunit |
IC50 |
820.0 |
nM |
10.1016/j.bmcl.2020.127479 |
| Homo sapiens |
PI3-kinase p110-alpha subunit |
IC50 |
820.0 |
nM |
10.1016/j.ejmech.2016.11.014 |
| Homo sapiens |
PI3-kinase p110-alpha subunit |
IC50 |
820.0 |
nM |
10.1021/acs.jmedchem.1c00986 |
| Homo sapiens |
PI3-kinase p110-alpha subunit |
IC50 |
820.0 |
nM |
10.1021/acs.jmedchem.1c01520 |
| Homo sapiens |
PI3-kinase p110-alpha subunit |
IC50 |
820.0 |
nM |
10.1021/jm301522m |
| Homo sapiens |
PI3-kinase p110-alpha subunit |
IC50 |
820.0 |
nM |
10.1039/C2MD20044A |
| Homo sapiens |
PI3-kinase p110-alpha subunit |
IC50 |
822.0 |
nM |
10.1039/C8MD00556G |
| Homo sapiens |
PI3-kinase p110-alpha subunit |
IC50 |
1650.0 |
nM |
10.1016/j.ejmech.2016.11.014 |
| Homo sapiens |
PI3-kinase p110-alpha subunit |
IC50 |
8695.5 |
nM |
10.1021/acs.jmedchem.1c00004 |
| Homo sapiens |
PI3-kinase p110-alpha subunit |
IC50 |
9700.0 |
nM |
10.1016/j.bmcl.2015.01.001 |
| Homo sapiens |
PI3-kinase p110-alpha subunit |
IC50 |
10000.0 |
nM |
10.1021/acs.jmedchem.9b01499 |
| Homo sapiens |
PI3-kinase p110-alpha subunit |
IC50 |
nan |
None |
10.1021/acs.jmedchem.1c00004 |
| Homo sapiens |
PI3-kinase p110-beta subunit |
IC50 |
120.1 |
nM |
10.1016/j.bmc.2018.03.002 |
| Homo sapiens |
PI3-kinase p110-beta subunit |
IC50 |
129.0 |
nM |
10.1016/j.ejmech.2018.03.068 |
| Homo sapiens |
PI3-kinase p110-beta subunit |
IC50 |
134.0 |
nM |
10.1016/j.bmc.2019.05.043 |
| Homo sapiens |
PI3-kinase p110-beta subunit |
IC50 |
139.1 |
nM |
10.1016/j.bmc.2019.07.051 |
| Homo sapiens |
PI3-kinase p110-beta subunit |
IC50 |
154.0 |
nM |
10.1016/j.ejmech.2019.03.005 |
| Homo sapiens |
PI3-kinase p110-beta subunit |
IC50 |
198.0 |
nM |
10.1016/j.bmcl.2023.129152 |
| Homo sapiens |
PI3-kinase p110-beta subunit |
IC50 |
281.0 |
nM |
10.1039/C8MD00556G |
| Homo sapiens |
PI3-kinase p110-beta subunit |
IC50 |
380.0 |
nM |
10.1016/j.bmcl.2017.01.077 |
| Homo sapiens |
PI3-kinase p110-beta subunit |
IC50 |
380.0 |
nM |
10.1021/acs.jmedchem.7b00618 |
| Homo sapiens |
PI3-kinase p110-beta subunit |
IC50 |
500.0 |
nM |
10.1016/j.bmcl.2020.127479 |
| Homo sapiens |
PI3-kinase p110-beta subunit |
IC50 |
562.0 |
nM |
10.1021/jm301522m |
| Homo sapiens |
PI3-kinase p110-beta subunit |
IC50 |
564.0 |
nM |
10.1021/acs.jmedchem.1c00986 |
| Homo sapiens |
PI3-kinase p110-beta subunit |
IC50 |
565.0 |
nM |
10.1016/j.bmcl.2020.127479 |
| Homo sapiens |
PI3-kinase p110-beta subunit |
IC50 |
565.0 |
nM |
10.1016/j.ejmech.2016.11.014 |
| Homo sapiens |
PI3-kinase p110-beta subunit |
IC50 |
565.0 |
nM |
10.1021/acs.jmedchem.1c01520 |
| Homo sapiens |
PI3-kinase p110-beta subunit |
IC50 |
565.0 |
nM |
10.1039/C2MD20044A |
| Homo sapiens |
PI3-kinase p110-beta subunit |
IC50 |
571.0 |
nM |
10.1016/j.bmcl.2019.04.007 |
| Homo sapiens |
PI3-kinase p110-beta subunit |
IC50 |
613.0 |
nM |
10.1016/j.bmc.2021.116312 |
| Homo sapiens |
PI3-kinase p110-beta subunit |
IC50 |
669.0 |
nM |
10.1016/j.ejmech.2016.11.014 |
| Homo sapiens |
PI3-kinase p110-beta subunit |
IC50 |
845.5 |
nM |
10.1016/j.ejmech.2018.07.036 |
| Homo sapiens |
PI3-kinase p110-beta subunit |
IC50 |
1400.0 |
nM |
10.1016/j.bmcl.2015.01.001 |
| Homo sapiens |
PI3-kinase p110-beta subunit |
IC50 |
1995.26 |
nM |
10.1021/acs.jmedchem.9b01499 |
| Homo sapiens |
PI3-kinase p110-beta subunit |
IC50 |
2473.5 |
nM |
10.1021/acs.jmedchem.1c00004 |
| Homo sapiens |
PI3-kinase p110-beta subunit |
IC50 |
4000.0 |
nM |
10.1021/acs.jmedchem.9b00640 |
| Homo sapiens |
PI3-kinase p110-beta subunit |
IC50 |
nan |
None |
10.1021/acs.jmedchem.1c00004 |
| Homo sapiens |
PI3-kinase p110-delta/p85-alpha |
IC50 |
1.08 |
nM |
10.1016/j.bmc.2021.116312 |
| Homo sapiens |
PI3-kinase p110-delta/p85-alpha |
IC50 |
1.8 |
nM |
10.1016/j.ejmech.2019.03.005 |
| Homo sapiens |
PI3-kinase p110-delta/p85-alpha |
IC50 |
2.0 |
nM |
10.1021/acs.jmedchem.8b02014 |
| Homo sapiens |
PI3-kinase p110-delta/p85-alpha |
IC50 |
2.7 |
nM |
10.1016/j.bmcl.2017.03.020 |
| Homo sapiens |
PI3-kinase p110-delta/p85-alpha |
IC50 |
3.4 |
nM |
10.1016/j.ejmech.2020.112143 |
| Homo sapiens |
PI3-kinase p110-delta/p85-alpha |
IC50 |
17.0 |
nM |
10.1016/j.ejmech.2018.09.033 |
| Homo sapiens |
PI3-kinase p110-delta/p85-alpha |
IC50 |
18.0 |
nM |
10.1021/acs.jmedchem.6b01821 |
| Homo sapiens |
PI3-kinase p110-delta/p85-alpha |
IC50 |
19.0 |
nM |
10.1021/acs.jmedchem.9b00640 |
| Homo sapiens |
PI3-kinase p110-delta/p85-alpha |
IC50 |
25.0 |
nM |
10.1021/acs.jmedchem.6b00963 |
| Homo sapiens |
PI3-kinase p110-delta/p85-alpha |
Inhibition |
50.0 |
% |
10.1021/acs.jmedchem.8b02014 |
| Homo sapiens |
PI3-kinase p110-delta/p85-alpha |
Inhibition |
96.0 |
% |
10.1016/j.bmcl.2017.03.020 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
Activity |
nan |
None |
10.1021/acs.jmedchem.0c00193 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
EC50 |
8.0 |
nM |
10.1016/j.ejmech.2021.113218 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
1.0 |
nM |
10.1016/j.bmcl.2023.129152 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
1.2 |
nM |
10.1016/j.bmc.2019.07.051 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
1.6 |
nM |
10.1016/j.ejmech.2018.03.068 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
2.0 |
nM |
10.1016/j.bmcl.2017.01.077 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
2.0 |
nM |
10.1016/j.ejmech.2018.11.072 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
2.0 |
nM |
10.1016/j.ejmech.2021.113661 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
2.0 |
nM |
10.1021/acs.jmedchem.7b00618 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
2.0 |
nM |
10.1021/acsmedchemlett.6b00209 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
2.1 |
nM |
10.1016/j.bmcl.2019.04.007 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
2.5 |
nM |
10.1016/j.bmc.2018.03.002 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
2.5 |
nM |
10.1016/j.bmcl.2018.02.032 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
2.5 |
nM |
10.1016/j.bmcl.2020.127479 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
2.5 |
nM |
10.1016/j.ejmech.2016.11.014 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
2.5 |
nM |
10.1016/j.ejmech.2021.113218 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
2.5 |
nM |
10.1021/acs.jmedchem.1c00986 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
2.5 |
nM |
10.1021/acs.jmedchem.8b01298 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
2.5 |
nM |
10.1021/jm301522m |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
2.5 |
nM |
10.1039/C2MD20044A |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
2.5 |
nM |
None |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
2.7 |
nM |
10.1016/j.bmc.2018.03.002 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
2.7 |
nM |
10.1016/j.bmcl.2015.01.001 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
3.0 |
nM |
10.1039/C5MD00364D |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
3.1 |
nM |
10.1016/j.bmc.2019.05.043 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
3.2 |
nM |
10.1039/C8MD00556G |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
4.0 |
nM |
10.1021/acs.jmedchem.8b02014 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
4.3 |
nM |
10.1016/j.ejmech.2016.11.014 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
4.7 |
nM |
10.1016/j.bmcl.2020.127479 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
5.9 |
nM |
10.1016/j.ejmech.2018.07.036 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
6.0 |
nM |
10.1021/acs.jmedchem.0c01544 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
6.1 |
nM |
10.1021/jm300847w |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
7.0 |
nM |
10.1016/j.bmc.2022.117028 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
9.0 |
nM |
10.1016/j.ejmech.2016.02.018 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
9.0 |
nM |
10.1021/jm300847w |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
9.0 |
nM |
None |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
10.0 |
nM |
10.1021/acs.jmedchem.9b01499 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
19.0 |
nM |
10.1021/acs.jmedchem.8b01732 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
24.0 |
nM |
10.1016/j.bmcl.2015.01.001 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
25.0 |
nM |
10.1021/ml500354e |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
31.0 |
nM |
10.1021/acs.jmedchem.1c00004 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
48.93 |
nM |
10.1021/acs.jmedchem.1c00004 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
831.0 |
nM |
10.1016/j.bmcl.2019.04.007 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
IC50 |
nan |
None |
10.1021/acs.jmedchem.1c00004 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
Inhibition |
91.91 |
% |
10.1016/j.ejmech.2018.03.068 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
Inhibition |
96.0 |
% |
10.1016/j.bmc.2018.03.002 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
Inhibition |
96.0 |
% |
10.1016/j.bmcl.2019.04.007 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
Inhibition |
nan |
% |
10.1016/j.bmc.2021.116312 |
| Homo sapiens |
PI3-kinase p110-delta subunit |
Inhibition |
nan |
% |
10.1021/acsmedchemlett.6b00209 |
| Homo sapiens |
PI3-kinase p110-gamma subunit |
IC50 |
27.4 |
nM |
10.1016/j.bmc.2021.116312 |
| Homo sapiens |
PI3-kinase p110-gamma subunit |
IC50 |
50.5 |
nM |
10.1016/j.bmc.2022.117028 |
| Homo sapiens |
PI3-kinase p110-gamma subunit |
IC50 |
60.0 |
nM |
10.1016/j.bmcl.2023.129152 |
| Homo sapiens |
PI3-kinase p110-gamma subunit |
IC50 |
60.0 |
nM |
10.1039/C8MD00556G |
| Homo sapiens |
PI3-kinase p110-gamma subunit |
IC50 |
63.0 |
nM |
10.1016/j.bmcl.2017.01.077 |
| Homo sapiens |
PI3-kinase p110-gamma subunit |
IC50 |
63.0 |
nM |
10.1016/j.ejmech.2018.11.072 |
| Homo sapiens |
PI3-kinase p110-gamma subunit |
IC50 |
63.0 |
nM |
10.1016/j.ejmech.2019.03.005 |
| Homo sapiens |
PI3-kinase p110-gamma subunit |
IC50 |
63.0 |
nM |
10.1021/acs.jmedchem.7b00618 |
| Homo sapiens |
PI3-kinase p110-gamma subunit |
IC50 |
64.0 |
nM |
10.1021/acsmedchemlett.6b00209 |
| Homo sapiens |
PI3-kinase p110-gamma subunit |
IC50 |
67.0 |
nM |
10.1016/j.ejmech.2018.07.036 |
| Homo sapiens |
PI3-kinase p110-gamma subunit |
IC50 |
89.0 |
nM |
10.1016/j.bmcl.2020.127479 |
| Homo sapiens |
PI3-kinase p110-gamma subunit |
IC50 |
89.0 |
nM |
10.1016/j.ejmech.2016.11.014 |
| Homo sapiens |
PI3-kinase p110-gamma subunit |
IC50 |
89.0 |
nM |
10.1021/acs.jmedchem.1c00986 |
| Homo sapiens |
PI3-kinase p110-gamma subunit |
IC50 |
89.0 |
nM |
10.1021/acs.jmedchem.1c01520 |
| Homo sapiens |
PI3-kinase p110-gamma subunit |
IC50 |
89.0 |
nM |
10.1021/acs.jmedchem.8b01298 |
| Homo sapiens |
PI3-kinase p110-gamma subunit |
IC50 |
89.0 |
nM |
10.1021/jm301522m |
| Homo sapiens |
PI3-kinase p110-gamma subunit |
IC50 |
89.0 |
nM |
10.1039/C2MD20044A |
| Homo sapiens |
PI3-kinase p110-gamma subunit |
IC50 |
92.0 |
nM |
10.1016/j.bmcl.2019.04.007 |
| Homo sapiens |
PI3-kinase p110-gamma subunit |
IC50 |
92.0 |
nM |
10.1039/C5MD00364D |
| Homo sapiens |
PI3-kinase p110-gamma subunit |
IC50 |
104.0 |
nM |
10.1021/acs.jmedchem.8b02014 |
| Homo sapiens |
PI3-kinase p110-gamma subunit |
IC50 |
139.0 |
nM |
10.1016/j.ejmech.2018.03.068 |
| Homo sapiens |
PI3-kinase p110-gamma subunit |
IC50 |
139.4 |
nM |
10.1016/j.bmc.2018.03.002 |
| Homo sapiens |
PI3-kinase p110-gamma subunit |
IC50 |
145.3 |
nM |
10.1016/j.bmc.2019.07.051 |
| Homo sapiens |
PI3-kinase p110-gamma subunit |
IC50 |
199.53 |
nM |
10.1021/acs.jmedchem.9b01499 |
| Homo sapiens |
PI3-kinase p110-gamma subunit |
IC50 |
241.0 |
nM |
10.1016/j.ejmech.2016.11.014 |
| Homo sapiens |
PI3-kinase p110-gamma subunit |
IC50 |
245.0 |
nM |
10.1016/j.bmcl.2020.127479 |
| Homo sapiens |
PI3-kinase p110-gamma subunit |
IC50 |
250.0 |
nM |
10.1016/j.ejmech.2018.09.033 |
| Homo sapiens |
PI3-kinase p110-gamma subunit |
IC50 |
381.0 |
nM |
10.1016/j.bmc.2019.05.043 |
| Homo sapiens |
PI3-kinase p110-gamma subunit |
IC50 |
580.0 |
nM |
10.1016/j.bmcl.2015.01.001 |
| Homo sapiens |
PI3-kinase p110-gamma subunit |
IC50 |
2100.0 |
nM |
10.1021/acs.jmedchem.6b01821 |
| Homo sapiens |
PI3-kinase p110-gamma subunit |
IC50 |
2100.0 |
nM |
10.1021/acs.jmedchem.9b00640 |
| Homo sapiens |
PI3-kinase p110-gamma subunit |
IC50 |
nan |
None |
10.1021/acs.jmedchem.1c00004 |
| Homo sapiens |
PI3-kinase p110-gamma subunit |
Inhibition |
50.0 |
% |
10.1021/acs.jmedchem.8b02014 |
| Homo sapiens |
PI3K p110 beta/p85 alpha |
IC50 |
293.0 |
nM |
10.1021/acs.jmedchem.8b02014 |
| Homo sapiens |
PI3K p110 beta/p85 alpha |
IC50 |
600.0 |
nM |
10.1016/j.ejmech.2018.09.033 |
| Homo sapiens |
PI3K p110 beta/p85 alpha |
IC50 |
3700.0 |
nM |
10.1021/acs.jmedchem.6b01821 |
| Homo sapiens |
PI3K p110 beta/p85 alpha |
IC50 |
3807.0 |
nM |
10.1016/j.ejmech.2018.11.072 |
| Homo sapiens |
PI3K p110 beta/p85 alpha |
Inhibition |
50.0 |
% |
10.1021/acs.jmedchem.8b02014 |
| Homo sapiens |
PI4-kinase alpha subunit |
IC50 |
10000.0 |
nM |
10.1016/j.ejmech.2018.07.036 |
| Homo sapiens |
PI4-kinase beta subunit |
IC50 |
10000.0 |
nM |
10.1016/j.ejmech.2018.07.036 |
| Homo sapiens |
Platelet-derived growth factor receptor beta |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
Activity |
3.7 |
% |
10.1016/j.bmcl.2015.01.001 |
| Homo sapiens |
Probable ATP-dependent RNA helicase DDX6 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Protein kinase C alpha |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Protein kinase C beta |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Protein kinase C delta |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Protein kinase C iota |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Protein kinase C nu |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Protein kinase C theta |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Protein kinase N1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Protein kinase N2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Protein tyrosine kinase 2 beta |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Putative heat shock protein HSP 90-beta 2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Pyridoxal kinase |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Quinone reductase 2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Rab-like protein 3 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Raji |
IC50 |
9.95 |
nM |
10.1016/j.bmcl.2017.03.020 |
| Homo sapiens |
Raji |
IC50 |
9950.0 |
nM |
10.1016/j.bmc.2018.03.002 |
| Homo sapiens |
Raji |
IC50 |
10000.0 |
nM |
10.1016/j.bmc.2019.07.051 |
| Homo sapiens |
Ramos |
IC50 |
10.0 |
nM |
10.1016/j.bmcl.2017.03.020 |
| Homo sapiens |
Ramos |
IC50 |
10000.0 |
nM |
10.1016/j.bmc.2018.03.002 |
| Homo sapiens |
Ramos |
IC50 |
10000.0 |
nM |
10.1016/j.bmc.2019.07.051 |
| Homo sapiens |
Ras-related protein Rab-10 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Ras-related protein Rab-27A |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Ras-related protein Rab-6A |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Receptor-interacting serine/threonine-protein kinase 3 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Rho-associated protein kinase 1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Rho-associated protein kinase 2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Ribosomal protein S6 kinase 1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Ribosomal protein S6 kinase alpha 1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Ribosomal protein S6 kinase alpha 3 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Ribosomal protein S6 kinase alpha 4 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Ribosomal protein S6 kinase alpha 5 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Ribosomal protein S6 kinase alpha 6 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
RNA cytidine acetyltransferase |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
RPMI-8226 |
IC50 |
5490.0 |
nM |
10.1016/j.bmc.2018.03.002 |
| Homo sapiens |
RXF 393 |
GI50 |
1400.0 |
nM |
10.1021/acs.jmedchem.0c00193 |
| Homo sapiens |
S-adenosylmethionine synthase isoform type-2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Septin-9 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine-protein kinase ATR |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase 10 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase 11 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase 16 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase 2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase 24 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase 38 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase 38-like |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase AKT |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase AKT2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase AKT3 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase A-Raf |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase Aurora-A |
Delta TM |
-0.27 |
C |
None |
| Homo sapiens |
Serine/threonine-protein kinase Aurora-A |
Delta TM |
0.281 |
C |
None |
| Homo sapiens |
Serine/threonine-protein kinase Aurora-A |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase Aurora-B |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase B-raf |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase Chk1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase c-TAK1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase D2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase/endoribonuclease IRE1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase/endoribonuclease IRE2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase GAK |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase ICK |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase ILK-1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase LATS1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase MRCK-A |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase MRCK beta |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase MRCK gamma |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase MST1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase MST2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase MST4 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase mTOR |
IC50 |
1000.0 |
nM |
10.1016/j.bmcl.2019.04.007 |
| Homo sapiens |
Serine/threonine-protein kinase mTOR |
IC50 |
10000.0 |
nM |
10.1039/C2MD20044A |
| Homo sapiens |
Serine/threonine-protein kinase N3 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase Nek1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase NEK2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase Nek3 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase NEK9 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine protein kinase NLK |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase PAK 2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase PAK 4 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase PAK6 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase PCTAIRE-1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase PCTAIRE-2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase PIM1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase PLK1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase PLK4 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase RIPK2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase SIK2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase SIK3 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase TAO1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase TAO2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase TAO3 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase TBK1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase ULK1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase ULK3 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serine/threonine-protein kinase WEE1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
4604.6 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Signal recognition particle receptor subunit alpha |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
SNB-75 |
GI50 |
1200.0 |
nM |
10.1021/acs.jmedchem.0c00193 |
| Homo sapiens |
STE20-related kinase adapter protein alpha |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Structural maintenance of chromosomes protein 1A |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Structural maintenance of chromosomes protein 2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
SUD4 |
IC50 |
1600.0 |
nM |
10.1016/j.ejmech.2016.11.014 |
| Homo sapiens |
SU-DHL-1 |
IC50 |
10000.0 |
nM |
10.1016/j.ejmech.2016.11.014 |
| Homo sapiens |
SU-DHL10 |
Activity |
1.7 |
% |
10.1016/j.bmc.2021.116312 |
| Homo sapiens |
SU-DHL10 |
Activity |
12.2 |
% |
10.1016/j.bmc.2021.116312 |
| Homo sapiens |
SU-DHL10 |
Activity |
30.4 |
% |
10.1016/j.bmc.2021.116312 |
| Homo sapiens |
SU-DHL10 |
Activity |
55.7 |
% |
10.1016/j.bmc.2021.116312 |
| Homo sapiens |
SU-DHL10 |
IC50 |
10000.0 |
nM |
10.1016/j.ejmech.2016.11.014 |
| Homo sapiens |
SU-DHL-5 |
Activity |
41.34 |
% |
10.1016/j.bmc.2021.116312 |
| Homo sapiens |
SU-DHL-6 |
Activity |
1.25 |
g |
10.1021/acs.jmedchem.0c01264 |
| Homo sapiens |
SU-DHL-6 |
Activity |
1276.78 |
mm3 |
10.1021/acs.jmedchem.0c01264 |
| Homo sapiens |
SU-DHL-6 |
GI50 |
20.0 |
nM |
10.1039/C8MD00556G |
| Homo sapiens |
SU-DHL-6 |
GI50 |
34.0 |
nM |
10.1016/j.ejmech.2020.112143 |
| Homo sapiens |
SU-DHL-6 |
GI50 |
42.0 |
nM |
10.1016/j.ejmech.2018.03.068 |
| Homo sapiens |
SU-DHL-6 |
GI50 |
124.0 |
nM |
10.1016/j.ejmech.2019.03.005 |
| Homo sapiens |
SU-DHL-6 |
IC50 |
22.5 |
nM |
10.1021/acs.jmedchem.0c01264 |
| Homo sapiens |
SU-DHL-6 |
IC50 |
33.0 |
nM |
10.1016/j.bmc.2019.07.051 |
| Homo sapiens |
SU-DHL-6 |
IC50 |
53.0 |
nM |
10.1016/j.bmc.2022.117028 |
| Homo sapiens |
SU-DHL-6 |
IC50 |
117.6 |
nM |
10.1016/j.ejmech.2016.11.014 |
| Homo sapiens |
SU-DHL-6 |
IC50 |
120.0 |
nM |
10.1016/j.bmcl.2020.127479 |
| Homo sapiens |
SU-DHL-6 |
IC50 |
650.0 |
nM |
10.1016/j.bmc.2018.03.002 |
| Homo sapiens |
SU-DHL-6 |
TGI |
38.52 |
% |
10.1021/acs.jmedchem.0c01264 |
| Homo sapiens |
T47D |
GI50 |
5200.0 |
nM |
10.1021/acs.jmedchem.0c00193 |
| Homo sapiens |
T47D |
GI50 |
nan |
None |
10.1021/acsmedchemlett.7b00222 |
| Homo sapiens |
T47D |
IC50 |
510.0 |
nM |
10.1016/j.bmc.2022.117028 |
| Homo sapiens |
TGF-beta receptor type I |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
TGF-beta receptor type II |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Thrombin |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thyroid hormone receptor-associated protein 3 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
TMD8 |
Activity |
1.07 |
g |
10.1021/acs.jmedchem.0c01264 |
| Homo sapiens |
TMD8 |
Activity |
1312.58 |
mm3 |
10.1021/acs.jmedchem.0c01264 |
| Homo sapiens |
TMD8 |
IC50 |
7.3 |
nM |
10.1021/acs.jmedchem.0c01264 |
| Homo sapiens |
TMD8 |
IC50 |
795.0 |
nM |
10.1016/j.bmcl.2019.04.007 |
| Homo sapiens |
TMD8 |
TGI |
29.28 |
% |
10.1021/acs.jmedchem.0c01264 |
| Homo sapiens |
TP53-regulating kinase |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
TRAF2- and NCK-interacting kinase |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Transcription intermediary factor 1-alpha |
Delta TM |
-0.98 |
C |
None |
| Homo sapiens |
Transcription intermediary factor 1-alpha |
Delta TM |
-0.2391 |
C |
None |
| Homo sapiens |
Tyrosine- and threonine-specific cdc2-inhibitory kinase |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Tyrosine kinase non-receptor protein 2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Tyrosine-protein kinase ABL |
Delta TM |
-0.1913 |
C |
None |
| Homo sapiens |
Tyrosine-protein kinase ABL |
Delta TM |
0.82 |
C |
None |
| Homo sapiens |
Tyrosine-protein kinase ABL |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Tyrosine-protein kinase ABL2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Tyrosine-protein kinase BRK |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Tyrosine-protein kinase BTK |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Tyrosine-protein kinase CSK |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Tyrosine-protein kinase FER |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Tyrosine-protein kinase FES |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Tyrosine-protein kinase FGR |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Tyrosine-protein kinase FRK |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Tyrosine-protein kinase FYN |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Tyrosine-protein kinase HCK |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Tyrosine-protein kinase JAK1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Tyrosine-protein kinase LCK |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Tyrosine-protein kinase Lyn |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Tyrosine-protein kinase receptor FLT3 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Tyrosine-protein kinase receptor RET |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Tyrosine-protein kinase SRC |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Tyrosine-protein kinase SYK |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Tyrosine-protein kinase TEC |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Tyrosine-protein kinase TYK2 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Tyrosine-protein kinase YES |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Tyrosyl-tRNA synthetase |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
U-251 |
GI50 |
53200.0 |
nM |
10.1021/acs.jmedchem.0c00193 |
| Homo sapiens |
U2OS |
Control DMSO Apoptotic Cells (%) |
0.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Apoptotic Cells (%) |
24.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Apoptotic Cells (%) |
31.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Apoptotic Cells (%) |
36.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Apoptotic Cells (%) |
37.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Apoptotic Cells (%) |
59.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Fragmented Nuclei % |
4.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Fragmented Nuclei % |
5.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Fragmented Nuclei % |
6.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Fragmented Nuclei % |
7.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Fragmented Nuclei % |
8.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Growth Rate |
0.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Growth Rate |
1.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Healthy Nuclei (%) |
87.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Healthy Nuclei (%) |
88.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Healthy Nuclei (%) |
91.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Membrane Permeable-Phenotype Cells (%) |
6.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Membrane Permeable-Phenotype Cells (%) |
8.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Membrane Permeable-Phenotype Cells (%) |
9.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Membrane Permeable-Phenotype Cells (%) |
10.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Mitochondria Different-Phenotype Cells (%) |
12.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Mitochondria Different-Phenotype Cells (%) |
18.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Mitochondria Different-Phenotype Cells (%) |
21.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Mitochondria Different-Phenotype Cells (%) |
24.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Mitochondria Different-Phenotype Cells (%) |
29.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Mitotic Cells (%) |
0.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Mitotic Cells (%) |
40.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Mitotic Cells (%) |
62.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Mitotic Cells (%) |
63.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Mitotic Cells (%) |
68.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Mitotic Cells (%) |
75.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Pyknosed Nuclei (%) |
3.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Pyknosed Nuclei (%) |
4.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Pyknosed Nuclei (%) |
5.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Total Cells |
99.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Total Cells |
139.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Total Cells |
156.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Total Cells |
178.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Total Cells |
199.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Total Cells |
276.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Tubulin Phenotype Different Cells (%) |
26.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Tubulin Phenotype Different Cells (%) |
27.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Tubulin Phenotype Different Cells (%) |
28.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Control DMSO Tubulin Phenotype Different Cells (%) |
31.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Growth Rate |
-0.03 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
U2OS |
Growth Rate |
0.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Growth Rate |
0.06 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
U2OS |
Growth Rate |
0.4 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
U2OS |
Growth Rate |
0.44 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
U2OS |
Growth Rate |
0.46 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
U2OS |
Growth Rate |
0.55 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
U2OS |
Growth Rate |
0.59 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
U2OS |
Growth Rate |
0.68 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
U2OS |
Growth Rate |
0.73 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
U2OS |
Growth Rate |
0.92 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
U2OS |
Growth Rate |
0.94 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
U2OS |
Growth Rate |
1.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Apoptotic (%) |
0.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Apoptotic (%) |
14.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Apoptotic (%) |
30.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Apoptotic (%) |
33.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Apoptotic (%) |
40.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Apoptotic (%) |
42.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Apoptotic (%) |
45.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Apoptotic (%) |
46.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Fragmented Nuclei (%) |
1.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Fragmented Nuclei (%) |
3.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Fragmented Nuclei (%) |
5.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Fragmented Nuclei (%) |
6.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Fragmented Nuclei (%) |
7.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Fragmented Nuclei (%) |
8.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Fragmented Nuclei (%) |
9.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Fragmented Nuclei (%) |
10.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Fragmented Nuclei (%) |
14.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Healthy Nuclei (%) |
77.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Healthy Nuclei (%) |
82.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Healthy Nuclei (%) |
84.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Healthy Nuclei (%) |
85.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Healthy Nuclei (%) |
86.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Healthy Nuclei (%) |
88.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Healthy Nuclei (%) |
91.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Healthy Nuclei (%) |
93.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Hoechst High Intensity Objects (%) |
3.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Hoechst High Intensity Objects (%) |
5.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Hoechst High Intensity Objects (%) |
6.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Hoechst High Intensity Objects (%) |
8.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Hoechst High Intensity Objects (%) |
9.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Hoechst High Intensity Objects (%) |
11.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Hoechst High Intensity Objects (%) |
13.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Hoechst High Intensity Objects (%) |
16.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Hoechst High Intensity Objects (%) |
20.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Membrane Permeable-Phenotype (%) |
2.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Membrane Permeable-Phenotype (%) |
4.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Membrane Permeable-Phenotype (%) |
6.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Membrane Permeable-Phenotype (%) |
8.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Membrane Permeable-Phenotype (%) |
10.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Membrane Permeable-Phenotype (%) |
28.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Membrane Permeable-Phenotype (%) |
32.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Membrane Permeable-Phenotype (%) |
45.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Membrane Permeable-Phenotype (%) |
47.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Mitochondria Different-Phenotype (%) |
8.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Mitochondria Different-Phenotype (%) |
9.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Mitochondria Different-Phenotype (%) |
10.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Mitochondria Different-Phenotype (%) |
12.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Mitochondria Different-Phenotype (%) |
13.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Mitochondria Different-Phenotype (%) |
15.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Mitochondria Different-Phenotype (%) |
18.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Mitochondria Different-Phenotype (%) |
19.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Mitochondria Different-Phenotype (%) |
28.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Mitochondria Different-Phenotype (%) |
30.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Mitotic Cells (%) |
0.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Mitotic Cells (%) |
53.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Mitotic Cells (%) |
54.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Mitotic Cells (%) |
57.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Mitotic Cells (%) |
60.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Mitotic Cells (%) |
66.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Mitotic Cells (%) |
70.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Mitotic Cells (%) |
85.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Mitotic Cells (%) |
100.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Normal (%) |
79.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Normal (%) |
83.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Normal (%) |
86.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Normal (%) |
88.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Normal (%) |
90.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Normal (%) |
91.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Normal (%) |
93.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Normal (%) |
94.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Normal (%) |
96.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Pyknosed Nuclei (%) |
0.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Pyknosed Nuclei (%) |
1.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Pyknosed Nuclei (%) |
2.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Pyknosed Nuclei (%) |
5.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Pyknosed Nuclei (%) |
7.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Pyknosed Nuclei (%) |
9.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Pyknosed Nuclei (%) |
10.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Pyknosed Nuclei (%) |
13.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Tubulin-Different-Phenotype (%) |
15.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Tubulin-Different-Phenotype (%) |
17.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Tubulin-Different-Phenotype (%) |
20.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Tubulin-Different-Phenotype (%) |
21.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Tubulin-Different-Phenotype (%) |
24.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Tubulin-Different-Phenotype (%) |
25.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Tubulin-Different-Phenotype (%) |
27.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Tubulin-Different-Phenotype (%) |
34.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Tubulin-Different-Phenotype (%) |
90.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Tubulin-Different-Phenotype (%) |
93.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Population Tubulin-Different-Phenotype (%) |
94.0 |
% |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Total Cell Count |
95.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Total Cell Count |
103.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Total Cell Count |
130.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Total Cell Count |
132.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Total Cell Count |
134.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Total Cell Count |
146.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Total Cell Count |
148.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Total Cell Count |
162.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Total Cell Count |
180.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Total Cell Count |
210.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Total Cell Count |
244.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U5 small nuclear ribonucleoprotein 200 kDa helicase |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
U-87 MG |
GI50 |
nan |
None |
10.1021/acsmedchemlett.7b00222 |
| Homo sapiens |
Uncharacterized aarF domain-containing protein kinase 1 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Uncharacterized aarF domain-containing protein kinase 5 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Uncharacterized protein FLJ45252 |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Homo sapiens |
Vascular endothelial growth factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Very long-chain specific acyl-CoA dehydrogenase, mitochondrial |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1021/acs.jmedchem.1c00004 |
| Mus musculus |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform |
IC50 |
1302.0 |
nM |
10.1021/acs.jmedchem.1c00004 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Rattus norvegicus |
AUC |
422.0 |
ng.hr.mL-1 |
10.1016/j.bmc.2018.03.002 |
| Rattus norvegicus |
Rattus norvegicus |
Cmax |
310.52 |
nM |
10.1016/j.bmc.2018.03.002 |
| Rattus norvegicus |
Rattus norvegicus |
F |
39.0 |
% |
10.1016/j.bmc.2018.03.002 |
| Rattus norvegicus |
Rattus norvegicus |
ID50 |
1.6 |
mg.kg-1 |
10.1021/acsmedchemlett.6b00438 |
| Rattus norvegicus |
Rattus norvegicus |
T1/2 |
1.52 |
hr |
10.1016/j.bmc.2018.03.002 |
| Rattus norvegicus |
Synaptic vesicular amine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
-0.9913 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
9.69 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
30.29 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
-0.08519 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.4259 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-4.09 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.23 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.1 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.18 |
% |
10.6019/CHEMBL4495565 |
| None |
ADMET |
Activity |
20.68 |
g |
10.1021/acs.jmedchem.0c01264 |
| None |
ADMET |
Activity |
23.84 |
g |
10.1021/acs.jmedchem.0c01264 |
| None |
ADMET |
Activity |
25.03 |
g |
10.1021/acs.jmedchem.0c01264 |
| None |
ADMET |
Activity |
nan |
None |
10.1016/j.bmc.2021.116312 |
| None |
ADMET |
AUC |
201.88 |
ng.hr.mL-1 |
10.1016/j.bmc.2021.116312 |
| None |
ADMET |
AUC |
512.0 |
ng.hr.mL-1 |
10.1021/acsmedchemlett.6b00438 |
| None |
ADMET |
AUC |
924.0 |
ng.hr.mL-1 |
10.1021/acsmedchemlett.6b00438 |
| None |
ADMET |
AUC |
1396.0 |
ng.hr.mL-1 |
10.1016/j.ejmech.2019.03.005 |
| None |
ADMET |
AUC |
3086.64 |
ng.hr.mL-1 |
10.1021/acs.jmedchem.0c01264 |
| None |
ADMET |
AUC |
3191.0 |
ng.hr.mL-1 |
10.1016/j.ejmech.2019.03.005 |
| None |
ADMET |
AUC |
3842.73 |
ng.hr.mL-1 |
10.1021/acs.jmedchem.0c01264 |
| None |
ADMET |
CL |
0.76 |
mL.min-1.kg-1 |
10.1021/acs.jmedchem.0c01264 |
| None |
ADMET |
CL |
3.8 |
mL.min-1.g-1 |
10.1021/acs.jmedchem.1c00004 |
| None |
ADMET |
CL |
5.25 |
uL.min-1.(10^6cells)-1 |
10.6019/CHEMBL3301361 |
| None |
ADMET |
CL |
19.5 |
uL.min-1.(10^6cells)-1 |
10.6019/CHEMBL3301361 |
| None |
ADMET |
CL |
21.5 |
mL.min-1.kg-1 |
10.1021/acsmedchemlett.6b00438 |
| None |
ADMET |
CL |
21.88 |
mL.min-1.g-1 |
10.6019/CHEMBL3301361 |
| None |
ADMET |
CL |
24.5 |
mL.min-1.kg-1 |
10.1016/j.ejmech.2019.03.005 |
| None |
ADMET |
CL |
32.8 |
mL.min-1.kg-1 |
10.1021/acsmedchemlett.6b00438 |
| None |
ADMET |
CL |
47.8 |
mL.min-1.kg-1 |
10.1021/acs.jmedchem.0c01264 |
| None |
ADMET |
CL |
54.0 |
mL.min-1.kg-1 |
10.1021/acs.jmedchem.0c01264 |
| None |
ADMET |
Cmax |
127.63 |
nM |
10.1016/j.bmc.2021.116312 |
| None |
ADMET |
Cmax |
310.0 |
nM |
10.1021/acs.jmedchem.0c01264 |
| None |
ADMET |
Cmax |
500.0 |
nM |
10.1021/acs.jmedchem.0c01264 |
| None |
ADMET |
Cmax |
3460.0 |
nM |
10.1021/acs.jmedchem.0c01264 |
| None |
ADMET |
Cmax |
5577.35 |
nM |
10.1016/j.ejmech.2019.03.005 |
| None |
ADMET |
Cmax |
6980.0 |
nM |
10.1021/acs.jmedchem.0c01264 |
| None |
ADMET |
Cp |
0.02 |
uM |
10.1021/acs.jmedchem.0c01264 |
| None |
ADMET |
Cp |
0.03 |
uM |
10.1021/acs.jmedchem.0c01264 |
| None |
ADMET |
Cp |
0.04 |
uM |
10.1021/acs.jmedchem.0c01264 |
| None |
ADMET |
Drug metabolism |
20.0 |
% |
10.1021/acsmedchemlett.6b00438 |
| None |
ADMET |
Drug metabolism |
21.0 |
% |
10.1021/acsmedchemlett.6b00438 |
| None |
ADMET |
Drug uptake |
0.08 |
uM |
10.1021/acs.jmedchem.0c01264 |
| None |
ADMET |
Drug uptake |
0.14 |
uM |
10.1021/acs.jmedchem.0c01264 |
| None |
ADMET |
Drug uptake |
0.15 |
uM |
10.1021/acs.jmedchem.0c01264 |
| None |
ADMET |
F |
37.6 |
% |
10.1021/acs.jmedchem.0c01264 |
| None |
ADMET |
F |
39.0 |
% |
10.1021/acs.jmedchem.0c01264 |
| None |
ADMET |
F |
45.8 |
% |
10.1016/j.ejmech.2019.03.005 |
| None |
ADMET |
F |
48.0 |
% |
10.1021/acs.jmedchem.0c01264 |
| None |
ADMET |
F |
68.0 |
% |
10.1021/acsmedchemlett.6b00438 |
| None |
ADMET |
PPB |
81.01 |
% |
10.6019/CHEMBL3301361 |
| None |
ADMET |
Stability |
nan |
% |
10.1021/acs.jmedchem.8b02014 |
| None |
ADMET |
T1/2 |
0.43 |
hr |
10.1021/acs.jmedchem.0c01264 |
| None |
ADMET |
T1/2 |
0.519 |
hr |
10.1016/j.ejmech.2019.03.005 |
| None |
ADMET |
T1/2 |
0.8 |
hr |
10.1021/acsmedchemlett.6b00438 |
| None |
ADMET |
T1/2 |
0.83 |
hr |
10.1021/acs.jmedchem.0c01264 |
| None |
ADMET |
T1/2 |
1.03 |
hr |
10.1016/j.ejmech.2019.03.005 |
| None |
ADMET |
T1/2 |
1.52 |
hr |
10.1021/acs.jmedchem.0c01264 |
| None |
ADMET |
T1/2 |
1.6 |
hr |
10.1021/acsmedchemlett.6b00438 |
| None |
ADMET |
T1/2 |
1.89 |
hr |
10.1021/acs.jmedchem.0c01264 |
| None |
ADMET |
T1/2 |
1.99 |
hr |
10.1021/acs.jmedchem.0c01264 |
| None |
ADMET |
T1/2 |
2.31 |
hr |
10.1021/acs.jmedchem.0c01264 |
| None |
ADMET |
T1/2 |
2.7 |
hr |
10.1016/j.bmc.2021.116312 |
| None |
ADMET |
T1/2 |
6.079 |
hr |
10.1021/acs.jmedchem.1c00004 |
| None |
ADMET |
Tmax |
0.08 |
hr |
10.1021/acs.jmedchem.0c01264 |
| None |
ADMET |
Tmax |
0.25 |
hr |
10.1021/acs.jmedchem.0c01264 |
| None |
ADMET |
Tmax |
0.5 |
hr |
10.1016/j.bmc.2021.116312 |
| None |
ADMET |
Tmax |
1.0 |
hr |
10.1021/acs.jmedchem.0c01264 |
| None |
ADMET |
Tmax |
3.0 |
hr |
10.1021/acs.jmedchem.0c01264 |
| None |
ADMET |
Vdss |
0.73 |
L.kg-1 |
10.1021/acs.jmedchem.0c01264 |
| None |
ADMET |
Vdss |
0.884 |
L.kg-1 |
10.1016/j.ejmech.2019.03.005 |
| None |
ADMET |
Vdss |
2.49 |
L.kg-1 |
10.1021/acs.jmedchem.0c01264 |
| None |
Neutrophil |
IC50 |
70.0 |
nM |
10.1016/j.bmcl.2017.06.029 |
| None |
Neutrophil |
IC50 |
300.0 |
nM |
10.1016/j.bmcl.2017.06.029 |
| None |
Neutrophil |
Inhibition |
99.6 |
% |
10.1016/j.bmcl.2017.06.029 |
| None |
Neutrophil |
Inhibition |
102.8 |
% |
10.1016/j.bmcl.2017.06.029 |
| None |
NON-PROTEIN TARGET |
IC50 |
100.0 |
nM |
10.1021/acs.jnatprod.6b00118 |
| None |
NON-PROTEIN TARGET |
IC50 |
300.0 |
nM |
10.1021/acs.jnatprod.6b00118 |
| None |
NON-PROTEIN TARGET |
IC50 |
3600.0 |
nM |
10.1021/acsmedchemlett.6b00209 |
| None |
NON-PROTEIN TARGET |
IC50 |
6300.0 |
nM |
10.1021/acsmedchemlett.6b00209 |
| None |
NON-PROTEIN TARGET |
IC50 |
7900.0 |
nM |
10.1021/acsmedchemlett.6b00209 |
| None |
NON-PROTEIN TARGET |
IC50 |
8400.0 |
nM |
10.1021/acsmedchemlett.6b00209 |
| None |
NON-PROTEIN TARGET |
IC50 |
10000.0 |
nM |
10.1021/acsmedchemlett.6b00209 |
| None |
NON-PROTEIN TARGET |
IC50 |
10600.0 |
nM |
10.1021/acsmedchemlett.6b00209 |
| None |
NON-PROTEIN TARGET |
ID50 |
15.0 |
mg.kg-1 |
10.1021/acsmedchemlett.6b00438 |
| None |
NON-PROTEIN TARGET |
Inhibition |
100.0 |
% |
10.1021/acs.jnatprod.6b00452 |
| None |
NON-PROTEIN TARGET |
Inhibition |
103.0 |
% |
10.1021/acs.jnatprod.6b00452 |
| None |
NON-PROTEIN TARGET |
Inhibition |
nan |
% |
10.1021/acs.jnatprod.6b00452 |
| None |
NON-PROTEIN TARGET |
Vd |
2.2 |
L.kg-1 |
10.1021/acsmedchemlett.6b00438 |
| None |
NON-PROTEIN TARGET |
Vd |
2.5 |
L.kg-1 |
10.1021/acsmedchemlett.6b00438 |
| None |
No relevant target |
LogD7.4 |
2.72 |
None |
10.6019/CHEMBL3301361 |
| None |
Unchecked |
Activity |
0.5 |
% |
10.1016/j.ejmech.2021.113661 |
| None |
Unchecked |
Activity |
1.14 |
% |
10.1016/j.ejmech.2021.113661 |
| None |
Unchecked |
Activity |
1.49 |
% |
10.1016/j.ejmech.2021.113661 |
| None |
Unchecked |
Activity |
2.6 |
% |
10.1016/j.ejmech.2021.113661 |
| None |
Unchecked |
Activity |
3.44 |
% |
10.1016/j.ejmech.2021.113661 |
| None |
Unchecked |
Activity |
5.71 |
% |
10.1016/j.ejmech.2021.113661 |
| None |
Unchecked |
Activity |
7.95 |
% |
10.1016/j.ejmech.2021.113661 |
| None |
Unchecked |
Activity |
9.19 |
% |
10.1016/j.ejmech.2021.113661 |
| None |
Unchecked |
Activity |
10.1 |
% |
10.1016/j.ejmech.2021.113661 |
| None |
Unchecked |
Activity |
12.4 |
% |
10.1016/j.ejmech.2021.113661 |
| None |
Unchecked |
Activity |
13.6 |
% |
10.1016/j.ejmech.2021.113661 |
| None |
Unchecked |
Activity |
13.9 |
% |
10.1016/j.ejmech.2021.113661 |
| None |
Unchecked |
Activity |
14.8 |
% |
10.1016/j.ejmech.2021.113661 |
| None |
Unchecked |
Activity |
18.2 |
% |
10.1016/j.ejmech.2021.113661 |
| None |
Unchecked |
Activity |
31.7 |
% |
10.1016/j.ejmech.2021.113661 |
| None |
Unchecked |
Activity |
32.8 |
% |
10.1016/j.ejmech.2021.113661 |
| None |
Unchecked |
Activity |
32.9 |
% |
10.1016/j.ejmech.2021.113661 |
| None |
Unchecked |
Activity |
47.9 |
% |
10.1016/j.ejmech.2021.113661 |
| None |
Unchecked |
Activity |
48.4 |
% |
10.1016/j.ejmech.2021.113661 |
| None |
Unchecked |
Activity |
49.6 |
% |
10.1016/j.ejmech.2021.113661 |
| None |
Unchecked |
Activity |
73.2 |
% |
10.1016/j.ejmech.2021.113661 |
| None |
Unchecked |
Activity |
74.6 |
% |
10.1016/j.ejmech.2021.113661 |
| None |
Unchecked |
Activity |
77.0 |
% |
10.1016/j.ejmech.2021.113661 |
| None |
Unchecked |
IC50 |
5.49 |
nM |
10.1016/j.bmcl.2017.03.020 |
| None |
Unchecked |
IC50 |
337.0 |
nM |
10.1021/acs.jmedchem.8b02014 |
| None |
Unchecked |
IC50 |
846.0 |
nM |
10.1021/acs.jmedchem.8b01298 |
| None |
Unchecked |
IC50 |
10000.0 |
nM |
10.1016/j.ejmech.2016.11.014 |
| None |
Unchecked |
IC50 |
10000.0 |
nM |
10.1039/C2MD20044A |
| None |
Unchecked |
IC50 |
13300.0 |
nM |
10.1016/j.bmcl.2023.129152 |
| None |
Unchecked |
IC50 |
20000.0 |
nM |
10.1021/acs.jmedchem.9b00969 |
| None |
Unchecked |
IC50 |
978000.0 |
nM |
10.1021/ml500354e |
| None |
Unchecked |
Kd |
30000.0 |
nM |
10.1126/science.aan4368 |
| None |
Unchecked |
Ratio IC50 |
2.5 |
None |
None |
| None |
Unchecked |
Ratio IC50 |
7.2 |
None |
10.1016/j.bmc.2022.117028 |
| None |
Unchecked |
Ratio IC50 |
11.0 |
None |
10.1021/acs.jmedchem.0c01544 |
| None |
Unchecked |
Ratio IC50 |
19.0 |
None |
10.1039/C8MD00556G |
| None |
Unchecked |
Ratio IC50 |
20.0 |
None |
10.1021/acs.jmedchem.7b00618 |
| None |
Unchecked |
Ratio IC50 |
21.0 |
None |
10.1021/jm300847w |
| None |
Unchecked |
Ratio IC50 |
25.37 |
None |
10.1016/j.bmc.2021.116312 |
| None |
Unchecked |
Ratio IC50 |
33.0 |
None |
10.1016/j.bmc.2019.05.043 |
| None |
Unchecked |
Ratio IC50 |
35.0 |
None |
10.1016/j.ejmech.2019.03.005 |
| None |
Unchecked |
Ratio IC50 |
36.0 |
None |
10.1021/jm301522m |
| None |
Unchecked |
Ratio IC50 |
49.0 |
None |
10.1021/jm300847w |
| None |
Unchecked |
Ratio IC50 |
65.0 |
None |
10.1021/acs.jmedchem.0c01544 |
| None |
Unchecked |
Ratio IC50 |
67.0 |
None |
10.1016/j.bmc.2022.117028 |
| None |
Unchecked |
Ratio IC50 |
80.0 |
None |
10.1016/j.ejmech.2018.03.068 |
| None |
Unchecked |
Ratio IC50 |
85.0 |
None |
10.1016/j.ejmech.2019.03.005 |
| None |
Unchecked |
Ratio IC50 |
86.0 |
None |
10.1016/j.ejmech.2018.03.068 |
| None |
Unchecked |
Ratio IC50 |
88.0 |
None |
10.1039/C8MD00556G |
| None |
Unchecked |
Ratio IC50 |
100.0 |
None |
10.1016/j.bmc.2019.05.043 |
| None |
Unchecked |
Ratio IC50 |
106.0 |
None |
10.1016/j.bmcl.2020.127479 |
| None |
Unchecked |
Ratio IC50 |
141.0 |
None |
10.1021/acs.jmedchem.0c01544 |
| None |
Unchecked |
Ratio IC50 |
225.0 |
None |
10.1021/jm301522m |
| None |
Unchecked |
Ratio IC50 |
230.0 |
None |
10.1021/acs.jmedchem.8b01298 |
| None |
Unchecked |
Ratio IC50 |
248.0 |
None |
10.1021/jm300847w |
| None |
Unchecked |
Ratio IC50 |
257.0 |
None |
10.1039/C8MD00556G |
| None |
Unchecked |
Ratio IC50 |
328.0 |
None |
10.1021/jm301522m |
| None |
Unchecked |
Ratio IC50 |
330.0 |
None |
10.1021/acs.jmedchem.8b01298 |
| None |
Unchecked |
Ratio IC50 |
460.0 |
None |
10.1016/j.ejmech.2018.03.068 |
| None |
Unchecked |
Ratio IC50 |
1202.0 |
None |
10.1016/j.ejmech.2019.03.005 |